fbpx

2026 TD Five Boro Bike Tour

2026 TD Five Boro Bike Tour

May 3, 2026

The National Blood Clot Alliance is thrilled to announce that we are returning as an official charity partner of the 2026 TD Five Boro Bike Tour, hosted by Bike New York.

On Sunday, May 3, 2026, cyclists of all skill levels will come from around the world to roll through every borough of New York City on streets totally free of cars. For one day, the roads are yours, the bridges are yours, the city is yours. There’s no better way to experience NYC. Forty miles, zero cars, endless memories.

Don’t have a bike? That’s okay! Check out Bike New York’s rental resources.

Why Join Team Stop the Clot?

Beyond a doubt, we’re one of the most supportive, energetic and fun charity teams. Sporting red polka dot shirts and other team gear, you’ll see us across the globe increasing blood clot awareness at 5Ks, 10Ks, marathons and cycling events.

Charity Rider Benefits

  • Registration paid for by NBCA
  • Guaranteed placement in the first start wave
  • Team Stop the Clot cycling shirt
  • Fundraising resources
  • Rider Identification Kit (helmet cover, bib, and bike plate) – this is your key to enter and participate in the tour
  • Snacks and entertainment at rest areas along the route
  • Fully supported route with additional water stops
  • Access to free bike repair along the route (labor is free; parts may cost extra)
  • Lunch in the charity enclosure at the Finish Festival on Staten Island

The National Blood Clot Alliance has been allotted 20 bibs with guaranteed entry into the event. Entries are non-refundable, non-transferable, and non-deferable. Every participant is required to raise $1,500 before the event.

The registration deadline is Wednesday, April 22, 2026 at 5 p.m. ET.

Current News

NFL Player Partners with NBCA for ‘My Cause My Cleats’

Patriots Long Snapper Julian Ashby Honors Late Teammate Bryce Stanfield Through NFL’s “My Cause My Cleats,” Supporting the National Blood…

FDA Expands Approval of THROMBATE III® to Include Children With Hereditary Antithrombin Deficiency

Grifols announced yesterday that the U.S. Food and Drug Administration (FDA) has expanded approval of THROMBATE III® to include children…